56055-54-0 Usage
General Description
Methyl 5,6-Dichloronicotinate is an organic chemical compound belonging to the class of organic compounds known as pyridinecarboxylic acids and derivatives. The chemical is most prominently characterized by a pyridine ring bearing a carboxylic acid substitute. Its systematic name is methyl 5,6-dichloropyridine-3-carboxylate. The compound's chemical structure comprises a pyridine ring with two chlorine atoms, indicating a chlorinated pyridine derivative. Its chemical formula is C7H4Cl2NO2 and has a molar mass of 216.02 g/mol. It is moderately soluble in water and has a strong odor. METHYL 5,6-DICHLORONICOTINATE is generally used in the synthesis of other more complex compounds and chemicals. As with many other chemicals, it needs to be handled with care because of its potential toxicity.
Check Digit Verification of cas no
The CAS Registry Mumber 56055-54-0 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 5,6,0,5 and 5 respectively; the second part has 2 digits, 5 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 56055-54:
(7*5)+(6*6)+(5*0)+(4*5)+(3*5)+(2*5)+(1*4)=120
120 % 10 = 0
So 56055-54-0 is a valid CAS Registry Number.
InChI:InChI=1/C7H5Cl2NO2/c1-12-7(11)4-2-5(8)6(9)10-3-4/h2-3H,1H3
56055-54-0Relevant articles and documents
INHIBITORS OF MALT1 AND USES THEREOF
-
Paragraph 00391, (2018/09/28)
Provided herein are compounds that inhibit MALTl, a protein whose activity is responsible for constitutive NF-κΒ signaling in certain cancers (e.g., activated B-cell diffuse large B-cell lymphoma (ABC-DLBCL)). Also provided are pharmaceutical compositions and kits comprising the compounds, and methods of treating MALTl -related diseases and disorders (e.g., cancer) with the compounds in a subject, by administering the compounds and/or compositions described herein.
NOVEL COMPOUNDS
-
Page/Page column 22, (2015/12/17)
The preseent invention relates to novel retinoid-related orphan receptor gamma(RORγ)modulators and their use in the treatment ofdiseases mediated by RORγ.
NOVEL COMPOUNDS
-
Page/Page column 76; 77, (2015/12/17)
Disclosed are novel retinoid-related orphan receptor gamma (RORγ) modulators and their use in the treatment of diseases mediated by RORγ.
